OPKO's ModeX partners with Regeneron on multispecific antibodies
Go back to OPKO's ModeX partners with Regeneron on multispecific antibodies| OPKO HEALTH, Inc. (NASDAQ: OPK) | Delayed: 1.46 +0.06 (4.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.40 | 52 Week High | $11.85 | |||
| Open | $1.39 | 52 Week Low | $7.12 | |||
| Day High | $1.47 | P/E | N/A | |||
| Day Low | $1.37 | EPS | $-0.30 | |||
| Volume | 4,752,056 | |||||
| Regeneron (NASDAQ: REGN) | Delayed: 618.95 +16.03 (2.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $602.92 | 52 Week High | $592.36 | |||
| Open | $600.79 | 52 Week Low | $325.35 | |||
| Day High | $625.00 | P/E | 162.45 | |||
| Day Low | $599.00 | EPS | $3.81 | |||
| Volume | 986,431 | |||||
